US Patent 7803790 Compounds for modulating TRPV3 function
Patent 7803790 was granted and assigned to Hydra Biosciences on September, 2010 by the United States Patent and Trademark Office.
All edits
Edits on 31 Oct, 2023
Golden AI
Edits made to:
Article (+128 characters)
Article
Patent abstract
The present application relates to compounds and methods for treating pain and other conditions related to TRPV3.
Edits on 25 May, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 07803790 Compounds for modulating TRPV3 function US Patent 7803790 Compounds for modulating TRPV3 function
Infobox
Patent Number
0780379000
Patent Number
780379000
Edits on 23 Mar, 2023
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
078037900
Date of Patent
September 28, 2010
0Patent Application Number
114319420
Date Filed
May 9, 2006
0Official Website
Patent Primary Examiner
Edits on 23 Sep, 2022
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
078037900
Date of Patent
September 28, 2010
0Patent Application Number
114319420
Date Filed
May 9, 2006
0Official Website
Patent Primary Examiner
Edits on 3 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 5 Dec, 2021
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 07803790 Compounds for modulating TRPV3 function
Infobox
Is a
Current assignee
Patent jurisdiction
Patent number
07803790
Date of patent
September 28, 2010
Patent application number
11431942
Date Filed
May 9, 2006
Patent primary examiner
Find more entities like US Patent 7803790 Compounds for modulating TRPV3 function
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
